Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center

Bibliographic Details
Main Authors: Jesko Momotow, Helen Goergen, Karolin Behringer, Paul J. Bröckelmann, Sven Borchmann, Bastian v. Tresckow, Carsten Kobe, Andreas Engert, Stephanie Sasse
Format: Article
Language:English
Published: Wolters Kluwer 2019-10-01
Series:HemaSphere
Online Access:http://journals.lww.com/10.1097/HS9.0000000000000293
id doaj-6bf3cb51d40b414cb275f0c6438a869b
record_format Article
spelling doaj-6bf3cb51d40b414cb275f0c6438a869b2020-11-25T01:23:00ZengWolters KluwerHemaSphere2572-92412019-10-013510.1097/HS9.0000000000000293201910000-00009Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-CenterJesko MomotowHelen GoergenKarolin BehringerPaul J. BröckelmannSven BorchmannBastian v. TresckowCarsten KobeAndreas EngertStephanie Sassehttp://journals.lww.com/10.1097/HS9.0000000000000293
collection DOAJ
language English
format Article
sources DOAJ
author Jesko Momotow
Helen Goergen
Karolin Behringer
Paul J. Bröckelmann
Sven Borchmann
Bastian v. Tresckow
Carsten Kobe
Andreas Engert
Stephanie Sasse
spellingShingle Jesko Momotow
Helen Goergen
Karolin Behringer
Paul J. Bröckelmann
Sven Borchmann
Bastian v. Tresckow
Carsten Kobe
Andreas Engert
Stephanie Sasse
Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
HemaSphere
author_facet Jesko Momotow
Helen Goergen
Karolin Behringer
Paul J. Bröckelmann
Sven Borchmann
Bastian v. Tresckow
Carsten Kobe
Andreas Engert
Stephanie Sasse
author_sort Jesko Momotow
title Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
title_short Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
title_full Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
title_fullStr Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
title_full_unstemmed Nivolumab in Relapsed/Refractory Classical Hodgkin Lymphoma – Extended Follow-up of 30 Patients Treated Within the CheckMate 205 Trial in a Single-Center
title_sort nivolumab in relapsed/refractory classical hodgkin lymphoma – extended follow-up of 30 patients treated within the checkmate 205 trial in a single-center
publisher Wolters Kluwer
series HemaSphere
issn 2572-9241
publishDate 2019-10-01
url http://journals.lww.com/10.1097/HS9.0000000000000293
work_keys_str_mv AT jeskomomotow nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
AT helengoergen nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
AT karolinbehringer nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
AT pauljbrockelmann nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
AT svenborchmann nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
AT bastianvtresckow nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
AT carstenkobe nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
AT andreasengert nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
AT stephaniesasse nivolumabinrelapsedrefractoryclassicalhodgkinlymphomaextendedfollowupof30patientstreatedwithinthecheckmate205trialinasinglecenter
_version_ 1725124111874654208